BioCentury | Nov 16, 2019
Company News
Management tracks: Lonza CEO to step down; plus Arrowhead, Insmed, Inozyme, Yukin, Pfenex, EyePoint, Verseau, Abingworth, CBC, Flagship, Diverse, Theragnostics,
...head of business development and licensing at the Novartis Institutes for BioMedical Research. Oncology company Diverse Biotech Inc....
...Ltd. Insmed Inc. Pfenex Inc. EyePoint Pharmaceuticals Inc. Verseau Therapeutics Inc. Abingworth CBC Group Flagship Pioneering Inozyme Pharma Inc. Orion Biotechnology Canada Ltd. Arrowhead Pharmaceuticals Inc. Diverse Biotech Inc....
...Ltd. Insmed Inc. Pfenex Inc. EyePoint Pharmaceuticals Inc. Verseau Therapeutics Inc. Abingworth CBC Group Flagship Pioneering Inozyme Pharma Inc. Orion Biotechnology Canada Ltd. Arrowhead Pharmaceuticals Inc. Diverse Biotech Inc....
